Can anyone clue me into what started the price drop from March 18?
At the moment, BAL seems to be trading on a PE of 21-22.
That seems pretty damn good for a company that apparently was "turning things around" in the last 12 months (according to their commentary). I remember reading something that happend last year in regards to BAL. Some regulatory change?
That's to be expected. But has this impacts BALs results?
Does this change have to do with claims of health benefits in certain products?
BAL Price at posting:
$8.78 Sentiment: None Disclosure: Not Held
